Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.
Breaking News:
- Hotpack hosts day out for 1,500 employees at Dubai Miracle Garden
- Dubai Chamber of Commerce hosts 64 business groups and councils during second quarterly roundtable meeting
- Celebrate Mother’s Day with a Luxurious Daycation at Al Jaddaf Rotana
- Warner Bros. Discovery Announces May Lineup Across TLC, Discovery, HGTV, discovery+ and Fatafeat
- Celebrate the Spirit of Eid Al Adha in the Heart of Makkah at Address Jabal Omar Makkah
- Ducab to showcase future-focused industrial strategy at Make it in the Emirates 2026
- Tech Mahindra Announces the Acquisition of Avant Techno Solutions to Expand Payment Modernization and Wealth Management Capabilities
- GEMS Modern Academy achieves 100% pass rate in ICSE and ISC, with exceptional student performance
Friday, May 1